A regulator would tell companies that compliance heads should not report to legal

This blog has commented before on the reporting lines of chief compliance officers (CCO’s) (See my post of Jan. 20, 2009: reporting lines of compliance function with 11 references.).

It had not occurred to me that government agencies might take a position. According to an article in Compliance Week by John Soriano, “the Office of the Inspector General of the Department of Health and Human Services has taken a clear position: Compliance and legal functions should be separate, and the CCO should not report the General Counsel.” For pharma companies, this message might lead to structural change.